Primerica's Third-Quarter Diluted EPS Rises 6% to $6.76 as Record Investment Product Sales of $4.4 Billion Offset a 12% Drop in Term Life Segment Income and a Shrinking Sales Force

Primerica, Inc. released its third-quarter 2026 results on November 4, 2026, with an earnings webcast on November 5. The company sells term life insurance and investment and savings products to middle-income households in North America through a large network of independent representatives. This article reports the figures from the results release filed with the U.S. Securities and Exchange Commission and notes where a number has been calculated here.

The headline numbers

Total revenues were $901.7 million, against $839.9 million in the third quarter of 2025, an increase of 7%. Income before income taxes was $271.9 million, essentially unchanged from $271.7 million. Net income was $209.1 million against $206.8 million, a rise of about 1%, and diluted earnings per share were $6.76 against $6.35, a rise of about 6% calculated here. The faster growth in per-share earnings reflects a lower share count: weighted average diluted shares fell to 30.8 million from 32.5 million because of share repurchases.

On the adjusted basis the company reports, adjusted net operating income was $209.3 million against $206.1 million, up 2%, and diluted adjusted operating earnings per share were $6.77 against $6.33, up 7%. The release notes that results include the annual actuarial assumption updates, which the company recognizes in the third quarter. The pre-tax gain from remeasurement of future policy benefits was $11.8 million against $23.1 million a year earlier, so that item contributed less to this year's quarter than to last year's. Return on stockholders' equity was 31.3%, and the adjusted return on adjusted stockholders' equity was 33.9%.

Term Life: revenue flat, income down

The Term Life Insurance segment is the company's largest. Adjusted operating revenues were $461.6 million against $463.3 million, effectively flat, but adjusted operating income before taxes fell about 12%, to $152.7 million from $172.7 million, a decline of $20.0 million calculated here. Adjusted direct premiums, a measure of premiums before reinsurance, rose 3% to $699.4 million, while reported net premiums were $453.6 million against $454.5 million.

New business was weaker. The face amount of term life insurance issued fell 5% to $25.7 billion from $27.1 billion, and the number of policies issued fell 7% to 73,813 from 79,379. Face amount in force was $969 billion. The release does not state the reasons for the lower segment income, so this article does not offer an explanation.

The sales force is smaller

Primerica's model depends on recruiting people to become licensed representatives. At the end of the quarter the life-licensed sales force was 147,058, down 3% from 152,200. Recruits were 90,818 against 101,156, down 10%, and new life-licensed representatives were 10,722 against 12,482, down 14%. Productivity, measured as average monthly policies issued per licensed representative, was 0.17, the same as a year earlier. With productivity unchanged, the 7% fall in policies issued is consistent with having fewer licensed representatives, though the release does not draw that connection explicitly and other factors may be involved.

Investment and Savings Products: a record

The Investment and Savings Products segment, had sales of $4.4 billion against $3.7 billion, up 19%, and the company described the figure as a record. Adjusted operating revenues rose 19% to $378.0 million, and adjusted operating income before taxes rose 21% to $114.1 million from $94.2 million. Client asset values at period end were $139.6 billion against $126.8 billion, up 10%, and net inflows were $407 million. The release does not separate how much of the revenue increase came from new sales and how much from other factors.

Corporate and Other Distributed Products had adjusted operating revenues of $62.2 million against $56.8 million, up 10%, and adjusted operating income before taxes of $5.3 million against $3.8 million. Closed brokered mortgage volume was $142.6 million against $143.4 million.

Capital and returns to stockholders

Primerica returned $159 million to stockholders in the quarter, made up of $122 million of share repurchases and $37 million of dividends. The board approved a dividend of $1.20 per share, payable on December 14, 2026 to stockholders of record on November 20, 2026. The estimated statutory risk-based capital ratio of Primerica Life Insurance Company was about 445% at September 30, 2026. Stockholders' equity was $2,826.6 million, up 16% from $2,445.9 million at December 31, 2025, while adjusted stockholders' equity, which removes the effect of unrealized gains and losses, was $2,496.5 million, up 4% from $2,400.6 million.

How to read the comparison

Two points are worth keeping in mind. First, the quarter's net income growth of 1% is smaller than the growth in per-share earnings of 6%, and the difference comes from buybacks rather than from the business growing faster. Second, the two main segments moved in opposite directions: income grew in Investment and Savings Products and fell in Term Life, so the total masks a shift in where earnings come from. Based on the segment figures, Investment and Savings Products income of $114.1 million is about 75% of Term Life income of $152.7 million, calculated here, up from about 55% a year earlier.

What the release does not say

The release does not include forward-looking financial guidance. It does not explain the decline in recruits or new licensees, and it does not give a view on demand for term life insurance in the market. CEO Glenn Williams attributed the quarter to consistent business fundamentals and an operating model aimed at middle-income families, and said stable Term Life earnings and record investment sales continue to drive earnings momentum.

What to watch

Three measures matter for the next few quarters: whether recruiting and the size of the sales force stabilize, whether policies issued recover, and whether Investment and Savings Products sales stay near the record level. This article is a summary of public figures and is not investment advice.